Skip to main content
Premium Trial:

Request an Annual Quote

John Fenn, Koichi Tanaka, Kurt Wthrich, Claes Wilhelmsson, Leigh Anderson, Susan Eddins, Jeffrey White

Premium

John Fenn of Virginia Commonwealth University and Koichi Tanaka of Shimadzu are two of the three winners of the 2002 Nobel Prize in Chemistry. They will receive the prize for their work developing soft ionization techniques for studying large biological molecules, such as proteins, by mass spectrometry. The other half of the prize goes to Kurt W thrich, of the Swiss Federal Institute of Technology and the Scripps Research Institute, for using NMR to study protein structure in solution.

Gyros has appointed Claes Wilhelmsson chairman of the board, the Uppsala, Sweden-based company said last week. Wilhelmsson, formerly the executive director and head of research and development at AstraZeneca, is currently a senior advisor to Investor Growth Capital, a subsidiary of Investor, based in Stockholm. Wilhelmsson retired from AstraZeneca in June, after 17 years with the company and its predecessor Astra. He began his career in 1969 as an academic researcher at the Sahlgrenska Hospital in Gothenburg, Sweden.

Leigh Anderson has joined diagnostics manufacturer Dade Behring’s scientific advisory board, he told ProteoMonitor last week. Anderson and his father, Norman, have also established the Anderson Forschung Group as a vehicle for their consulting services.

Susan Eddins has joined Illumina as worldwide head of marketing, the San Diego-based company said last week. In her new position, Eddins will be responsible for marketing and product management of the company’s BeadArray and Oligator technology product platform and services. Eddins joins Illumina from Applied Biosystems, where she served as director of genomic assays with responsibilites for commercialization strategies for the company’s genotyping and gene expression assays, as well as custom oligonucleotide synthesis. During her time at ABI, Eddins oversaw the product management and strategic marketing for the ABI Prism 3700 DNA Analyzer.

Jeffrey White has joined NaPro BioTherapeutics as president of its new genomics division, the Boulder, Colo.-based company said last week. White comes to NaPro from Agilent Technologies, where he served as vice president and general manager for biochemistries and services at the company’s life science and chemical analysis group. While at Agilent, White led the company’s entrance into genomics and proteomics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.